Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $5.6000 (-6.2%) ($5.6000 - $5.6000) on Wed. Jan. 27, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 15.45% (three month average) | RSI | 61 | Latest Price | $5.6000(-6.2%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -2.2% a day on average for past five trading days. | Weekly Trend | ANPC advances 2.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) QQQ(20%) HYG(19%) JNK(19%) IVW(18%) IWF(17%) | Factors Impacting ANPC price | ANPC will decline at least -7.725% in a week (0% probabilities). IGOV(-23%) VIXM(-16%) UNG(-12%) TLT(-9%) VXX(-6%) | | | | | Relative Volatility | | | | Market Trend Strength | -7.725% (StdDev 15.45%) | Hourly BBV | 1 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $5.77 | 5 Day Moving Average | $5.87(-4.6%) | 10 Day Moving Average | $5.89(-4.92%) | 20 Day Moving Average | $5.77(-2.95%) | To recent high | -20.6% | To recent low | 11.8% | Market Cap | $48m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |